R
Roy O. Mathew
Researcher at William Jennings Bryan Dorn VA Medical Center
Publications - 4
Citations - 29
Roy O. Mathew is an academic researcher from William Jennings Bryan Dorn VA Medical Center. The author has contributed to research in topics: Kidney disease & Renal function. The author has an hindex of 3, co-authored 4 publications receiving 18 citations.
Papers
More filters
Journal ArticleDOI
Pathophysiological Mechanisms in Cardiorenal Syndrome.
Janani Rangaswami,Roy O. Mathew +1 more
TL;DR: The ability to characterize the various facets of cardiorenal syndrome based on its pathophysiology is poised in an exciting vantage point, in the backdrop of several advanced diagnostic strategies, notably cardiolenal biomarkers that may help with accurate delineation of clinical phenotype, prognosis, and delivery of optimal medical therapies in future studies.
Journal ArticleDOI
Pharmacotherapeutic Management of Neuropathic Pain in End-Stage Renal Disease.
TL;DR: In the absence of pharmacokinetic data in ESRD patients, therapeutic window and potential risks should be factored in the decision making along with continued monitoring throughout therapy.
Journal ArticleDOI
Antihypertensive therapy in nondiabetic chronic kidney disease: a review and update.
TL;DR: This review is a comprehensive analysis of antihypertensive literature in nondiabetic renal disease, with a particular emphasis on BP target.
Journal ArticleDOI
Effect of intensive blood pressure on the progression of non-diabetic chronic kidney disease at varying degrees of proteinuria.
Paul Der Mesropian,Gulvahid Shaikh,Kelly Beers,Swati Mehta,Mauricio R Monrroy Prado,Krishnakumar Hongalgi,Roy O. Mathew,Paul J. Feustel,Loay Salman,Annalisa Perna,Elvira O. Gosmanova +10 more
TL;DR: In this article, the authors employed multivariable regression to evaluate the relationship between follow-up systolic blood pressure (SBP) and diastolic BP (DBP) on CKD progression (defined as glomerular filtration rate decline by 50% or end stage renal disease), focusing on the potential for effect modification by baseline proteinuria or albuminuria.